-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IRWAALqgLQvVJ5o0ubiRH3r+DTnG0tx6XrYwSE8CtsdLS2Y4pA4bdZ8wI4ONEwOR 5CQYbUU3/BBYQqsHsF2Bqg== 0000904454-98-000098.txt : 19980427 0000904454-98-000098.hdr.sgml : 19980427 ACCESSION NUMBER: 0000904454-98-000098 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980424 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TREGA BIOSCIENCES INC CENTRAL INDEX KEY: 0000887920 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 510336233 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: SEC FILE NUMBER: 005-45713 FILM NUMBER: 98600618 BUSINESS ADDRESS: STREET 1: 3550 GENERAL ATOMICS COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6194552544 MAIL ADDRESS: STREET 1: 3550 GENERAL ATOMICS COURT STREET 2: 3550 GENERAL ATOMICS COURT CITY: SANSAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: HOUGHTEN PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960215 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DOMAIN PARTNERS II LP CENTRAL INDEX KEY: 0000902406 STANDARD INDUSTRIAL CLASSIFICATION: [] STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: ONE PALMER SQUARE CITY: PRINCETON STATE: NJ ZIP: 08542 MAIL ADDRESS: STREET 1: ONE PALMER SQUARE CITY: PRINCETON STATE: NJ ZIP: 08542 SC 13D 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Trega Biosciences, Inc. __________________________________________________________________ (Name of Issuer) Common Stock, $.001 par value ___________________________________________________________________ (Title of Class of Securities) 0008946991 ___________________________________________________________________ (CUSIP Number) Kathleen K. SchoemakerJohn C. MacMurray, Esq. Domain AssociatesReboul, MacMurray, Hewitt, One Palmer Square Maynard & Kristol Princeton, New Jersey 0854245 Rockefeller Plaza Tel. (609) 683-5656New York, New York 10111 Tel. (212) 841-5700 ___________________________________________________________________ (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) March 27, 1998 ________________________________ (Date of Event Which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ]. CUSIP No. 0008946991 Page 2 of 11 ______________________________________________________________________ 1)Name of Reporting PersonDomain Partners II, S.S. or I.R.S. IdentificationL.P. No. of Above Person ______________________________________________________________________ 2)Check the Appropriate Box(a) [x] if a Member of a Group(b) [ ] ______________________________________________________________________ 3)SEC Use Only ______________________________________________________________________ 4)Source of Funds WC ______________________________________________________________________ 5) Check if Disclosure of Legal Proceedings isNot Applicable Required Pursuant to Items 2(d) or 2(e) ______________________________________________________________________ 6) Citizenship or Place of Organization Delaware ______________________________________________________________________ Number of 7)Sole Voting 1,444,084 shares of Shares Beneficially Power Common Stock Owned by Each Reporting Person: _____________________________________________ 8)Shared Voting Power -0- _____________________________________________ 9)Sole Disposi-1,444,084 shares of tive Power Common Stock _____________________________________________ 10) Shared Dis- positive Power -0- _____________________________________________ 11) Aggregate Amount Beneficially 1,444,084 shares of Owned by Each Reporting Person Common Stock ______________________________________________________________________ 12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares ______________________________________________________________________ 13) Percent of Class Represented by10.4% Amount in Row (11) ______________________________________________________________________ 14) Type of Reporting PersonPN CUSIP No. 0008946991 Page 3 of 11 1)Name of Reporting PersonDomain Partners III, S.S. or I.R.S. IdentificationL.P. No. of Above Person _______________________________________________________________________ 2)Check the Appropriate Box(a) [x] if a Member of a Group(b) [ ] _______________________________________________________________________ 3)SEC Use Only _______________________________________________________________________ Source of Funds WC 5) Check if Disclosure of Legal Proceedings isNot Applicable Required Pursuant to Items 2(d) or 2(e) _______________________________________________________________________ 6) Citizenship or Place of Organization Delaware Number of 7)Sole Voting 1,316,273 shares of Shares Beneficially Power Common Stock Owned by Each Reporting Person: 8)Shared Voting Power -0- 9)Sole Disposi-1,316,273 shares of tive Power Common Stock ______________________________________________ 10) Shared Dis- positive Power -0- ______________________________________________ 11) Aggregate Amount Beneficially 1,316,273 shares of Owned by Each Reporting Person Common Stock _______________________________________________________________________ 12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares _______________________________________________________________________ 13) Percent of Class Represented by9.5% Amount in Row (11) _______________________________________________________________________ 14) Type of Reporting Person PN CUSIP No. 0008946991 Page 4 of 11 _________________________________________________________________ 1)Name of Reporting PersonDP III Associates, S.S. or I.R.S. Identification L.P. No. of Above Person _________________________________________________________________ 2)Check the Appropriate Box(a) [x] if a Member of a Group(b) [ ] _________________________________________________________________ 3)SEC Use Only _________________________________________________________________ 4) Source of FundsWC _________________________________________________________________ 5) Check if Disclosure of Legal Proceedings isNot Applicable Required Pursuant to Items 2(d) or 2(e) _________________________________________________________________ 6) Citizenship or Place of Organization Delaware _________________________________________________________________ Number of 7)Sole Voting 45,703 shares of Shares Beneficially Power Common Stock Owned by Each Reporting Person: ________________________________________ 8) Shared Voting Power -0- ________________________________________ 9)Sole Disposi-45,703 shares of tive Power Common Stock ________________________________________ 10)Shared Dis- positive Power-0- ________________________________________ 11)Aggregate Amount Beneficially 45,703 shares of Owned by Each Reporting Person Common Stock _________________________________________________________________ 12)Check if the Aggregate Amount in Row (11) Excludes Certain Shares _________________________________________________________________ 13) Percent of Class Represented by0.3% Amount in Row (11) _________________________________________________________________ 14) Type of Reporting Person PN CUSIP No. 0008946991 Page 5 of 11 _________________________________________________________________ 1)Name of Reporting PersonDomain Associates S.S. or I.R.S. Identification No. of Above Person _________________________________________________________________ 2)Check the Appropriate Box(a) [x] if a Member of a Group(b) [ ] _________________________________________________________________ 3)SEC Use Only _________________________________________________________________ 4) Source of FundsNot Applicable _________________________________________________________________ 5) Check if Disclosure of Legal Proceedings isNot Applicable Required Pursuant to Items 2(d) or 2(e) _________________________________________________________________ 6) Citizenship or Place of Organization New Jersey _________________________________________________________________ Number of 7)Sole Voting 6,966 shares of Shares Beneficially Power Common Stock Owned by Each Reporting Person: ________________________________________ 8) Shared Voting Power -0- ________________________________________ 9)Sole Disposi-6,966 shares of tive Power Common Stock ________________________________________ 10)Shared Dis- positive Power-0- ________________________________________ 11)Aggregate Amount Beneficially 6,966 shares of Owned by Each Reporting Person Common Stock _________________________________________________________________ 12)Check if the Aggregate Amount in Row (11) Excludes Certain Shares _________________________________________________________________ 13) Percent of Class Represented byless than 0.1% Amount in Row (11) _________________________________________________________________ 14) Type of Reporting Person PN CUSIP No. 0008946991 Page 6 of 11 Schedule 13D _____________ Item 1.Security and Issuer. ___________________ This statement relates to the Common Stock, $.001 par value (the "Common Stock"), of Trega Biosciences, Inc., a Delaware corporation (the "Issuer"). The principal executive offices of the Issuer are located at 3550 General Atomics Court, San Diego, California 92121. Item 2. Identity and Background. _______________________ (a) Pursuant to Rules 13d-1(f)(1)-(2) of Regulation 13D-G of the General Rules and Regulations under the Securities Act of 1934, as amended (the "Act"), the undersigned hereby file this Schedule 13D on behalf of Domain Partners II L.P. ("DP II"), Domain Partners III, L.P., a Delaware limited partnership ("DP III"), DP III Associates, L.P., a Delaware limited partnership ("DPA") and Domain Associates, a New Jersey general partnership ("DA"). DP II, DP III, DPA and DA are sometimes hereinafter referred to as the "Reporting Persons". The Reporting Persons are making this single joint filing because they may be deemed to constitute a "group" within the meaning of Section 13(d)(3) of the Act. The agreement among the Reporting Persons to file as a group (the "Group Agreement") is attached hereto as Exhibit A. (b)-(c) DA is a New Jersey general partnership, whose principal business is that of an investment manager. DP II, DP III and DPA are Delaware limited partnerships, whose principal businesses are those of private investment partnerships. The sole general partner of DP II is One Palmer Square Associates II, L.P., a Delaware limited partnership ("OPSA II"), whose principal business is that of acting as the general partner of DP II. The sole general partner of DP III and DPA is One Palmer Square Associates III, L.P., a Delaware limited partnership ("OPSA III"), whose principal business is that of acting as the general partner of DP III and DPA. The following individuals, who are citizens of the United States, are the general partners of the entities listed after their names: (i) James C. Blair - DA, OPSA II and OPSA III (ii) Brian H. Dovey - DA, OPSA II and OPSA III (iii) Jesse I. Treu - DA, OPSA II and OPSA III (iv) Richard S. Schneider - DA, OPSA II and OPSA III (v) Kathleen K. Schoemaker - DA and OPSA III (vi)Arthur Klausner - DA The principal business and principal office address of each entity and individual named in this paragraph is One Palmer Square, Princeton, New Jersey 08542. CUSIP No. 0008946991 Page 7 of 11 (d) None of the entities or persons identified in this Item 2 has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e) None of the entities or persons identified in this Item 2 has, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. Item 3. Source and Amount of Funds or Other Consideration. _________________________________________________ This statement relates to the acquisition by DP III and DPA on March 2, 1998 through March 27, 1998 of an aggregate 237,550 shares of Common Stock at prices ranging from $3.56 to $5.01 per share, in open market purchases as further described in Item 5(c) below. The source of such funds was the working capital of DP III and DPA. Item 4. Purpose of Transaction. ______________________ The Reporting Persons have acquired securities of the Issuer for investment purposes. Item 5. Interest in Securities of the Issuer. ____________________________________ The following information is based on a total of 13,927,098 shares of Common Stock outstanding as of March 20, 1998, as reported in the Issuer's Annual Report on Form 10-K for the calendar year ended December 31, 1997. (a) DP II _____ DP II owns an aggregate 1,444,084 shares of Common Stock, or approximately 10.4% of the Common Stock outstanding. CUSIP No. 0008946991 Page 8 of 11 OPSA II _______ OPSA II, as the general partner of DP II, may be deemed to beneficially own the 1,444,084 shares of Common Stock owned by DP II, or approximately 10.4% of the Common Stock outstanding. DP III ______ DP III owns an aggregate 1,316,273 shares of Common Stock, or approximately 9.5% of the Common Stock outstanding. DPA ___ DPA owns an aggregate 45,703 shares of Common Stock, or approximately 0.3% of the Common Stock outstanding. OPSA III ________ OPSA III, as the general partner of DP III and DPA, may be deemed to beneficially own the aggregate 1,361,976 shares of Common Stock owned by DP III and DPA, or approximately 9.8% of the Common Stock outstanding. DA __ DA owns an aggregate 6,966 shares of Common Stock, or less than 0.1% of the Common Stock outstanding. (b) The general partners of OPSA II, OPSA III and DA may be deemed to share the power to vote or direct the voting of and to dispose or to direct the disposition of the shares of Common Stock owned by DP II, DP III, DPA and DA. Each of the general partners of OPSA II, OPSA III and DA disclaims beneficial ownership of all shares of Common Stock other than the shares of Common Stock he or she owns by virtue of his or her indirect pro rata interest, as a partner of OPSA II, OPSA III and DA, in the Common Stock owned by DP II, DP III, DPA and DA. CUSIP No. 0008946991 Page 9 of 11 (c) In the last sixty days DP III and DPA have purchased Common Stock in market transactions as follows: PurchaserDateNumber of SharesPrice per Share DP III3/02/98 7,250$3.56 DP III3/03/98 9,667$3.56 DP III3/04/98 4,835$3.56 DP III3/06/98 9,677$3.75 DP III3/09/9862,835$4.04 DP III3/10/9829,000$4.12 DP III3/11/9829,000$4.12 DP III3/12/98 9,677$4.06 DP III3/16/9819,334$3.98 DP III3/19/98 9,677$4.06 DP III3/20/98 9,677 $4.50 DP III3/24/9819,334$4.75 DP III3/27/9819,677$5.00 DPA 3/02/98 250$3.58 DPA3/03/98 333$3.57 DPA3/04/98 165$3.59 DPA3/06/98 333$3.76 DPA3/09/98 2,165$4.04 DPA3/10/98 1,000$4.13 DPA3/11/98 1,000$4.13 DPA3/12/98 333$4.07 DPA3/16/98 666$3.99 DPA3/19/98 333$4.07 DPA3/20/98 333$4.51 DPA3/24/98 666$4.76 DPA3/27/98 333$5.01 (d) Except as described in this statement, no person has the power to direct the receipt of dividends on, or the proceeds from sales of, the shares of Common Stock owned by DP II, DP III, DPA or DA. (e)Not applicable. Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. _______________________________________ Not Applicable. Item 7. Material to be Filed as Exhibits. ________________________________ Exhibit A - Group Agreement (Appears at Page 12) CUSIP No. 0008946991 Page 10 of 11 Signature _________ After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: April 22, 1998 DOMAIN PARTNERS II, L.P. By: One Palmer Square Associates II L.P., General Partner By /s/ Kathleen K. Schoemaker ___________________________________ Attorney-in-Fact DOMAIN PARTNERS III, L.P. By: One Palmer Square Associates III L.P., General Partner By /s/ Kathleen K. Schoemaker ____________________________________ General Partner DP III ASSOCIATES, L.P. By: One Palmer Square Associates III L.P., General Partner By /s/ Kathleen K. Schoemaker _____________________________________ General Partner DOMAIN ASSOCIATES By /s/ Kathleen K. Schoemaker ______________________________________ General Partner CUSIP No. 0008946991 Page 11 of 11 EXHIBIT A AGREEMENT OF DOMAIN PARTNERS II, L.P., DOMAIN PARTNERS III, L.P., DP III ASSOCIATES, L.P. AND DOMAIN ASSOCIATES PURSUANT TO RULE 13d-1(f) _____________________ The undersigned hereby agree that the Statement on Schedule 13D to which this Agreement is annexed as Exhibit A is filed on behalf of each of them in accordance with the provisions of 13d-1(f) under the Securities Exchange Act of 1934, as amended. DOMAIN PARTNERS II, L.P. By: One Palmer Square Associates II L.P., General Partner By /s/ Kathleen K. Schoemaker ___________________________________ Attorney-in-Fact DOMAIN PARTNERS III, L.P. By: One Palmer Square Associates III L.P., General Partner By /s/ Kathleen K. Schoemaker __________________________________ General Partner DP III ASSOCIATES, L.P. By: One Palmer Square Associates III L.P., General Partner By /s/ Kathleen K. Schoemaker __________________________________ General Partner DOMAIN ASSOCIATES By /s/ Kathleen k. Schoemaker __________________________________ General Partner Date: April 22, 1998 -----END PRIVACY-ENHANCED MESSAGE-----